Business
Sanofi’s R&D director leaves; Launching 2 new drugs for hemophilia, RSV in 2023

Sanofi’s R&D director leaves; Launching 2 new drugs for hemophilia, RSV in 2023
Sanofi’s R&D director leaves; Launching 2 new drugs for hemophilia, RSV in 2023